Skip Over Navigation Links

Media Mentions

Selected news articles and other coverage related to NIGMS’ Pharmacogenomics Research Network, a nationwide collaboration of scientists studying the effect of genes on people’s responses to a wide variety of medicines.
Genetic Tests Can Predict Who Needs Higher Doses of Plavix Link to external Web site
November 16, 2011 • USA Today
Family of Four Has Their Genome Sequenced Link to external Web site
September 16, 2011 • U.S. News & World Report
Mapping Your Genetic Code Link to external Web site
August 18, 2011 • WLS Chicago News

Genetic code mapping could lead to personalized medicine and possibly cure people with chronic disease.
Scientists Report Advance in Drug Repurposing Link to external Web site
August 17, 2011 • Wall Street Journal

In a bit of high-tech recycling, researchers have developed an innovative way to identify already-approved drugs that may work against diseases they weren't designed to combat.
Doctors Use Gene Sequence to Predict Health Risks Link to external Web site
April 29, 2010 • USA Today

Pharmacogenomics researchers analyzed the genome of a colleague to assess his risk of diseases and adverse drug responses.
DNA Test May Fine-Tune Warfarin Dosage Link to external Web site
February 27, 2009 • Health Day

A genetic test could make prescribing the widely used anticoagulant warfarin safer by predicting the lowest effective dose.
Tiny Gene Variations Can Even Alter Effect of the Pills We Take Link to external Web site
March 21, 2008 • The Wall Street Journal

Scientists are learning that even small genetic changes can make us more vulnerable to certain diseases or alter our responses to particular medicines.
The Genome Gets Personal—Almost Link to external Web site
March 19, 2008 • Journal of the American Medical Association

Commentary on the status of personalized medicine in routine clinical care and the outlook for the future.
Widely Used Blood Thinner Will Come With Genetic Instructions Link to external Web site
August 16, 2007 • Reuters

The blood thinner warfarin has become the first widely used drug that will include genetic tasting data on its label, moving personalized medicine into the mainstream.
A Conversation With Mary V. Relling: Saving Lives With Tailor-Made Medication Link to external Web site
August 29, 2006 • The New York Times

NIGMS grantee Mary V. Relling uses gene testing to customize medications for pediatric cancer patients.
Medical College Researcher Working to Make Genetic-Based Medicine a Reality Link to external Web site
August 1, 2006 • Wisconsin Technology Network

NIGMS is funding a researcher who aims to predict which patients will respond well to a class of drugs called thiopurines, which are used to treat inflammatory bowel disease and cancer, among other ailments.
Gene Test Promises to Find Right Drug, Right Dose Link to external Web site
July 20, 2006 • National Public Radio

New pharmacogenetic tests may help find the right dose of the right medicine for individual patients.
A Tale of Two Drugs Hints at Promise for Genetic Testing Link to external Web site
July 11, 2006 • New York Times

A review of several studies that examine genetic variations and how they influence an individual’s response to particular medications.

 
Up to top
This page last reviewed on January 25, 2012